Abstract
Chemotherapy-induced respiratory failure is being increasingly recognized as a cause of respiratory failure in the intensive care unit. The frequency of chemotherapy-induced respiratory failure is low, however with increasing number of patients receiving new chemotherapeutic agents more cases can be expected to be seen. Chemotherapy-induced respiratory failure can be due to bronchospasm and hypersensitivity reactions, pulmonary hemorrhage, interstitial pneumonitis, eosinophilic pneumonia, and non-cardiogenic pulmonary edema. Pulmonary and critical care physicians should be aware of the clinical presentation of chemotherapy-induced respiratory failure.
Keywords: Pulmonary toxicity, pneumonitis, respiratory failure, chemotherapy
Current Respiratory Medicine Reviews
Title: Respiratory Failure in Cancer Patients: Non-Infectious Complications of Antineoplastic Agents for Solid Tumors
Volume: 3 Issue: 3
Author(s): Bobbak Vahid and Paul E. Marik
Affiliation:
Keywords: Pulmonary toxicity, pneumonitis, respiratory failure, chemotherapy
Abstract: Chemotherapy-induced respiratory failure is being increasingly recognized as a cause of respiratory failure in the intensive care unit. The frequency of chemotherapy-induced respiratory failure is low, however with increasing number of patients receiving new chemotherapeutic agents more cases can be expected to be seen. Chemotherapy-induced respiratory failure can be due to bronchospasm and hypersensitivity reactions, pulmonary hemorrhage, interstitial pneumonitis, eosinophilic pneumonia, and non-cardiogenic pulmonary edema. Pulmonary and critical care physicians should be aware of the clinical presentation of chemotherapy-induced respiratory failure.
Export Options
About this article
Cite this article as:
Bobbak Vahid and Paul E. Marik , Respiratory Failure in Cancer Patients: Non-Infectious Complications of Antineoplastic Agents for Solid Tumors, Current Respiratory Medicine Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339807781387544
DOI https://dx.doi.org/10.2174/157339807781387544 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Current Neuropharmacology Chemistry of Plant Dyes: Applications and Environmental Implications of Dyeing Processes
Current Environmental Engineering Analgesia and Sedation in Mechanical Ventilation in Neonatology
Current Respiratory Medicine Reviews Invasive aspergillosis: adjunctive combination therapy
Mini-Reviews in Medicinal Chemistry Antidote Control of Aptamer Therapeutics: The Road to a Safer Class of Drug Agents
Current Pharmaceutical Biotechnology The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research Recent Patents in the Field of Radioprotector Development: Opportunities and Challenges
Recent Patents on Biotechnology Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets DL-3-n-Butylphthalide, an Anti-Oxidant Agent, Prevents Neurological Deficits and Cerebral Injury Following Stroke per Functional Analysis, Magnetic Resonance Imaging and Histological Assessment
Current Neurovascular Research Challenges in the Management of Paediatric Febrile Neutropenia
Current Pediatric Reviews Interleukin 2 in Cancer Therapy
Current Medicinal Chemistry The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management
Recent Patents on Anti-Infective Drug Discovery Nitroxides as Cancer Imaging Agents
Anti-Cancer Agents in Medicinal Chemistry Tolvaptan: A New Therapeutic Agent
Reviews on Recent Clinical Trials Surfactant Replacement Therapy in Pediatric Acute Lung Injury/Acute Respiratory Distress Syndrome
Current Respiratory Medicine Reviews